Merkkuri Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Merkkuri Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$446	–	108
2026 Q1	$446	Buy	+7	New	+$408	﹤0.01%	368

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Merkkuri Wealth Advisors's BMY Position: Q2 2026 in Review

Merkkuri Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7 shares — an estimated $446 sold.

Merkkuri Wealth Advisors first reported a position in BMY in Q1 2026 and held it in 1 quarter. The position peaked at $446 in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Merkkuri Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Merkkuri Wealth Advisors sold 7 Bristol-Myers Squibb shares in Q2 2026, an estimated $446.
Merkkuri Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and held it in 1 quarter.
Merkkuri Wealth Advisors's Bristol-Myers Squibb position peaked at $446 in Q1 2026.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Merkkuri Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.